Disease progressed in a predictable manner, which allowed experimental manipulation
Still, its a good potential customer acquisition strategy for Novo Nordisk, Leventhal said, because its tapping into a retailer that has a very, very loyal and large customer base. Overall, GLP-1s are getting cheaper, he added, because companies like Novo Nordisk and Eli Lilly, which makes GLP-1s Zepbound and Mounjaro, want to compete with the compounding market
Firstly, the guidance on this topic is based on expert consensus and is likely to evolve in the coming years
Tell your healthcare provider if you take diabetes medicines, especially insulin and sulfonylurea medicines
And no, that I was more decisive about what I wanted to eat